- Usual Dose of Simvastatin Does Not Inhibit Plaque Progression and Lumen Loss at the Peri-Stent Reference Segments after Bare-Metal Stent Implantation: A Serial Intravascular Ultrasound Analysis
-
Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC
- KMID: 964715
- Korean J Intern Med.
- 2010 Dec;25(4):356-363.
- doi: 10.3904/kjim.2010.25.4.356
BACKGROUND/AIMS: The aim of this study was to assess the effects of a usual dose of simvastatin (20 mg/day) on plaque regression and vascular remodeling at the peri-stent reference segments... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Combination Therapy of Felodipine and Ramipril on Plaque Regression and Plaque Compositional Changes in Patients with Hypertension and Angina with Mild to Moderate Degree of Coronary Stenosis
-
Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC
- KMID: 2330954
- J Korean Soc Hypertens.
- 2010 Mar;16(1):31-42.
BACKGROUND: Calcium channel blockers (CCB) and angiotensin converting enzyme (ACE) inhibitors can block the development of atherosclerosis. Fixed-dose combinations of a CCB, felodipine, and an ACE inhibitor, ramipril, are more... -
- CITED
-
- Close
- SHARE
-
- Close
